Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0200
-0.0100 (-33.33%)
Aug 10, 2026, 3:31 PM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 6.15 million as of August 10, 2026. Its market cap has decreased by -7.34% in one year.
Market Cap
6.15M
Enterprise Value
7.67M
Revenue
58.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 6.15M, an increase of 498.24%. That is a compound annual growth rate of 8.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.15M | -15.31% |
| Dec 30, 2025 | 7.26M | -51.98% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PreveCeutical Medical | 12.24M |
| Britannia Life Sciences | 10.55M |
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 9.62M |
| Restart Life Sciences | 5.30M |
| MYND Life Sciences | 5.22M |
| PharmaTher Holdings | 5.01M |
| XORTX Therapeutics | 4.85M |